LI
WST icon

LMCG Investments’s West Pharmaceutical WST Stock Holding History

LMCG Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,083
Closed -$217K – 565
2014
Q4 		$217K Buy
+4,083
New +$204K ﹤0.01% 509

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LMCG Investments's WST Position: Q1 2015 in Review

LMCG Investments sold out of West Pharmaceutical (WST) in Q1 2015, closing a stake of 4,083 shares — an estimated $217K sold.

LMCG Investments first reported a position in WST in Q4 2014 and held it in 1 quarter. The position peaked at $217K in Q4 2014. 213 funds tracked by Wall St. Rank hold WST as of Q1 2015.

  • LMCG Investments reported no remaining West Pharmaceutical position as of Q1 2015 after selling out during the quarter.
  • LMCG Investments sold 4,083 West Pharmaceutical shares in Q1 2015, an estimated $217K.
  • LMCG Investments first reported a position in West Pharmaceutical in Q4 2014 and held it in 1 quarter.
  • LMCG Investments's West Pharmaceutical position peaked at $217K in Q4 2014.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2015.

Based on LMCG Investments's 13F filing for Q1 2015, filed 15 May 2015.